Mitochondrial DNA alterations and statin-induced myopathy
Background/Objectives: Statins are widely used to treat hyperlipidemia and lower cardiovascular disease risk. While statins are generally well tolerated, ~10-15% of patients experience statin-induced myopathy (SIM), a potentially fatal complication. Statin treatment has been associated with mitoc...
Main Author: | |
---|---|
Format: | Others |
Language: | English |
Published: |
University of British Columbia
2009
|
Online Access: | http://hdl.handle.net/2429/9949 |